Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML

Clinical trial NCT07078591 · RECRUITING

Trial details

NCT number: NCT07078591
Sponsor: Beijing 302 Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2025-06-20
Primary completion: 2030-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.